Recap: Pieris Pharmaceuticals Q1 Earnings
Pieris Pharmaceuticals (NASDAQ:PIRS) reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Pieris Pharmaceuticals beat estimated earnings by 36.36%, reporting an EPS of $-0.07 versus an estimate of $-0.11.
Revenue was down $4.64 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.17 which was followed by a 3.26% increase in the share price the next day.
Here's a look at Pieris Pharmaceuticals's past performance:
|Quarter||Q4 2021||Q3 2021||Q2 2021||Q1 2021|
To track all earnings releases for Pieris Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.